Page last updated: 2024-09-03

dx 9065a and Myocardial Infarction

dx 9065a has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexander, JH; Armstrong, PW; Becker, RC; Berger, PB; Bovill, EG; Burton, JR; Cohen, EA; Dyke, CK; Goodman, S; Harrington, RA; Hochman, JS; Kawai, C; Kleiman, NS; Kodama, K; Lincoff, AM; Yang, H1

Trials

1 trial(s) available for dx 9065a and Myocardial Infarction

ArticleYear
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:3

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Dose-Response Relationship, Drug; Electrocardiography; Factor Xa Inhibitors; Female; Hemorrhage; Heparin; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Naphthalenes; Partial Thromboplastin Time; Propionates; Serine Endopeptidases

2005